References
- Wu C, Camacho FT, Zhao S, et al. Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stents. Ann Thorac Surg 2013;95(4):1297-305. https://doi.org/10.1016/j.athoracsur.2012.11.073
- Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2016;68(10):1082-115. https://doi.org/10.1016/j.jacc.2016.03.513
- Andell P, James SK, Cannon CP, et al. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial. J Am Heart Assoc 2015;4(10):e002490. https://doi.org/10.1161/JAHA.115.002490
- Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 2012;64(4):465-74. https://doi.org/10.1002/acr.21596
- Korean Knee Sciety. Guidelines for the management of postoperative pain after total knee arthroplasty. Knee Surg Relat Res 2012;24(4):201-7. https://doi.org/10.5792/ksrr.2012.24.4.201
- Greengard S, Kinman T. Managing Postoperative Pain, Swelling, and Bruising After Total Knee Replacement. Available from https://www.healthline.com/health/total-knee-replacement-surgery/manag-ing-postoperative-pain. Accessed April 20, 2018.
- Korea Centers for Disease Control & Prevention. Epidemiology and Management of Cardio-cerebrovascular Disease for Preventive Management of Community Cardio-cerebrovascular Disease 2013:518.
- Mauri L, Kereiakes DJ, Yeh RW, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. Engl J Med 2014;371(23):2155-66. https://doi.org/10.1056/NEJMoa1409312
- He F, Xia C, Zhang JH, et al. Clopidogrel plus aspirin versus aspirin alone for preventing early neurological deterioration in patients with acute ischemic stroke. J Clin Neurosci 2015;22(1):83-6. https://doi.org/10.1016/j.jocn.2014.05.038
- Liu Y, Liu H, Hao Y, et al. Short-term efficacy and safety of three different antiplatelet regimens in diabetic patients treated with primary percutaneous coronary intervention: a randomised study. Kardiol Pol 2017;75(9):850-8. https://doi.org/10.5603/KP.a2017.0116
- van Hecken A, Depre M, Wynants K, et al. Effect of clopidogrel on naproxen-induced gastrointestinal blood loss in healthy volunteers. Drug Metabol Drug Interact 1998;14(3):193-205.
- Liu L, Wong KS, Leng X, et al. Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCE. Neurology 2015;85(13):1154-62. https://doi.org/10.1212/WNL.0000000000001972
- Schafer AI. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 1995;35(3):209-19. https://doi.org/10.1002/j.1552-4604.1995.tb04050.x
- Meek IL, Van de Laar MA, H EV. Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks. Pharmaceuticals (Basel) 2010;3(7):2146-62. https://doi.org/10.3390/ph3072146
- Schror K. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis. Semin Thromb Hemost 1997;23(4):349-56. https://doi.org/10.1055/s-2007-996108
- Warner TD, Nylander S, Whatling C. Anti-platelet therapy: cyclo-oxygenase inhibition and the use of aspirin with particular regard to dual anti-platelet therapy. Br J Clin Pharmacol 2011;72(4):619-33. https://doi.org/10.1111/j.1365-2125.2011.03943.x